… tumor response patterns of HCRM to chemotherapy, establishes a simple five-point scoring
system to quantify the response as … between the histological response and survival in a large …

… Objective partial responses were observed in 11 of 18 patients. A total of 27 metastatic …
Pretreatment T:L ratios and SUVs did not correlate with tumor response, although response was …

… ,8 change in tumor diameter may not provide the best prognostic information. Morphologic
change in a treated metastasis may better reflect tumor response.9 When tumors change from …

… Generally, treatment consists of 4 cycles with the option of additional cycles in patients who
initially have a favorable tumor response and develop disease progression.108, 109 The …

… An early assessment of response is important for timely, … tumor response are poorly
associated with survival and result in few responders because the true effect of TACE is tumor …

… which liver metastases respond to molecular targeted therapy and help differentiate treatment
response … of treatment response and should be able to differentiate pseudoprogression of …

… is strongly influenced by the pathological response to preoperative chemotherapy. Indeed,
survival is influenced by a poor response of liver metastases to chemotherapy in case of R1 …

… The objective of this study was to determine the significance of a complete response of liver
metastases on imaging after chemotherapy. Two criteria were used: the correlation between …

… We hypothesized that these changes on CT reflect the pathologic response in patients …
of colorectal liver metastases. To test this hypothesis, we correlated tumor response based on …

… In conclusion, TACE is effective for patients with NET liver metastases to provide disease
control for 26 months and a 5.3-year median OS. Tumor response evaluation using RECIST …